It is a business services public limited company based in Seri Lingampally, Telangana, India, established in 2023.
2023 | Seri Lingampally, Telangana, India | ActiveAuro Pharma Limited, a active public limited company, was established on 22 November 2023 in Seri Lingampally, Telangana, India. it holds CIN: U46497TS2023PTC179262. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Formerly known as Auro Trading Private Limited. It upholds a compliant status. Its leadership includes Ranjit Kumar Gulla (Director), Thomas Koshy Vellutheril (Director), Srinivasa Ramachandra Rao Ilapakurthy (Director). Past directors included Nityananda Reddy Kambam, Madan Mohan Reddy Mettu. Its latest AGM occurred on 08 September 2025, with the balance sheet filed on 31 March 2025. It is based at Galaxy, Floors 22-24,, Plot No. 1 Survey No 83/1, Seri Lingampally, Telangana, 500032.
U46497TS2023PLC179262
179262
22 November 2023
₹1.00 M
₹1.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Auro Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ranjit Kumar Gulla | Director | 22 Nov 2023 | Current |
| Thomas Koshy Vellutheril | Director | 22 Nov 2023 | Current |
| Srinivasa Ramachandra Rao Ilapakurthy | Director | 22 Nov 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Non- Individual Subscriber | - | Past |
| Pramod Abcsdd | Individual Subscriber | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Auro Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Auro Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Auro Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Auro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auro Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Auro Pharma Limited last Annual general meeting of members was held on 08 Sep 2025 as per latest MCA records. was documented.
Progress on Auro Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
Progress on Ranjit Kumar Gulla was appointed as a Director was appointed as a Director on 22 Nov 2023 & has been associated with this company since 2 years 6 days . was documented.
Thomas Koshy Vellutheril was appointed as a Director was appointed as a Director on 22 Nov 2023 & has been associated with this company since 2 years 6 days . was recorded as a recent event.
The activity Srinivasa Ramachandra Rao Ilapakurthy was appointed as a Director was appointed as a Director on 22 Nov 2023 & has been associated with this company since 2 years 6 days . was completed.
Progress on Auro Pharma Limited was registered on 22 Nov 2023 with Roc Hyderabad & aged 2 years 6 days as per MCA records. was documented.
The CIN of Auro Pharma Limited is U46497TS2023PLC179262.
Auro Pharma Limited is headquartered at Galaxy, Floors 22-24,, Plot No. 1 Survey No 83/1, Seri Lingampally, Telangana, 500032.
Auro Pharma Limited was incorporated on 22 November 2023.
The current directors of Auro Pharma Limited are
Auro Pharma Limited is unlisted.
The authorized capital of Auro Pharma Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Auro Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX